This inventor holds 1 USPTO granted patent and 3 published patent applications and 2 EPO patents. Top assignees: Health Research, Inc., University of Kentucky Research Foundation. Active years: 2025.
Company Filing History:
1 out of 313 
1 out of 903 
Years Active: 2025
Title: Michael V Fiandalo: Innovator in Prostate Cancer Treatment
Introduction
Michael V Fiandalo is a notable inventor based in Buffalo, NY (US). He has made significant contributions to the field of cancer treatment, particularly focusing on prostate cancer. His innovative work has led to the development of unique compounds that may play a crucial role in inhibiting malignant cell growth.
Latest Patents
Fiandalo holds a patent for "Coumarin-modified androgens for the treatment of prostate cancer." This patent includes androstane and dihydrotestosterone compounds that are functionalized with carbocyclic or heterocyclic groups, which can be either saturated or unsaturated. These compounds are designed to inhibit the growth of malignant and hyperplastic cells, treat diseases associated with such growth, and facilitate molecular imaging of these cells. The patent also encompasses compositions that may induce the degradation of target proteins.
Career Highlights
Throughout his career, Michael V Fiandalo has worked with reputable organizations, including Health Research, Inc. and the University of Kentucky Research Foundation. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Fiandalo has collaborated with esteemed colleagues such as James L Mohler and David Watt. These partnerships have further enriched his research and development efforts in the field of cancer treatment.
Conclusion
Michael V Fiandalo's innovative work in developing compounds for prostate cancer treatment showcases his dedication to advancing medical science. His contributions are vital in the ongoing fight against cancer, and his patent reflects the potential for significant impact in this area.